NEW YORK, Oct 19 – Human Genome Sciences said Thursday that it would issue a public offering of 8,000,000 additional shares of its common stock, plus up to 1,200,000 shares to cover over-allotments, if any.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.